02/18/2025
7:25 PM | Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
| Form 10-Q/A | |
02/13/2025
7:00 AM | Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2025
6:30 AM | Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
02/10/2025
7:11 AM | Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/29/2025
5:13 AM | Grace Therapeutics, Inc. (Subject)
Grace Therapeutics (Subject)
HIRSCHMAN ORIN (Filed by)
| Form SCHEDULE 13G/A | |
11/14/2024
10:58 AM | BANK OF AMERICA CORP /DE/ (Filed by)
Grace Therapeutics, Inc. (Subject)
Grace Therapeutics (Subject)
| Form SC 13G/A | |
11/13/2024
7:00 AM | Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
6:30 AM | Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/28/2024
7:22 AM | Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/25/2024
7:13 AM | Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2024
11:15 PM | Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
| Form EFFECT | |
Get the Latest News and Ratings for GRCE and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Grace Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
10/15/2024
11:15 PM | Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
| Form EFFECT | |
10/08/2024
6:22 AM | Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
10/08/2024
6:13 AM | Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
| Form POS AM | |
10/08/2024
6:15 AM | Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
| Form POS AM | |
10/08/2024
6:16 AM | Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
| Form S-8 POS | |
10/08/2024
6:16 AM | Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
| Form S-8 POS | |
10/08/2024
6:16 AM | Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
| Form S-8 POS | |
09/30/2024
3:31 PM | Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/25/2024
7:00 AM | Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
7:00 AM | Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
6:30 AM | Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2024
3:14 PM | Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
| Form 424B3 | |
08/04/2024
11:15 PM | Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
| Form EFFECT | |
07/31/2024
6:22 AM | Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
| Form S-4/A | |
07/11/2024
10:16 AM | Acasti Pharma Inc. (Issuer)
Grace Therapeutics (Issuer)
ADAR1 Capital Management, LLC (Reporting)
ADAR1 Partners, LP (Reporting)
| Form 3/A | |
07/10/2024
8:10 PM | Acasti Pharma Inc. (Subject)
Grace Therapeutics (Subject)
ADAR1 Capital Management, LLC (Filed by)
| Form SC 13G | |
07/09/2024
7:29 PM | Acasti Pharma Inc. (Issuer)
Grace Therapeutics (Issuer)
ADAR1 Capital Management, LLC (Reporting)
ADAR1 Partners, LP (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/27/2024
4:01 PM | Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
| Form S-4
Registration statement under Securities Act of 1933 | |
06/21/2024
7:00 AM | Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2024
6:30 AM | Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
05/08/2024
6:18 PM | Acasti Pharma Inc. (Issuer)
Grace Therapeutics (Issuer)
Kohli Prashant (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
6:18 PM | Acasti Pharma Inc. (Issuer)
Grace Therapeutics (Issuer)
DelAversano Robert J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
6:19 PM | Acasti Pharma Inc. (Issuer)
Grace Therapeutics (Issuer)
Macdonald R. Loch (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
6:19 PM | Acasti Pharma Inc. (Issuer)
Grace Therapeutics (Issuer)
Kumar Amresh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
6:19 PM | Acasti Pharma Inc. (Issuer)
Grace Therapeutics (Issuer)
D'Andrea Carrie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2024
7:46 AM | Acasti Pharma Inc. (Subject)
Grace Therapeutics (Subject)
HIRSCHMAN ORIN (Filed by)
| Form SC 13G | |
04/01/2024
7:00 AM | Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
